Header Logo

Joan Lo

Concepts (433)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diphosphonates
19
2023
62
6.740
Why?
Bone Density Conservation Agents
16
2020
54
6.030
Why?
Osteoporosis
13
2024
74
5.160
Why?
Osteoporotic Fractures
10
2024
39
5.160
Why?
Bone Density
13
2024
92
4.030
Why?
Female
123
2024
12608
3.230
Why?
Femoral Fractures
6
2020
22
3.130
Why?
Breast Neoplasms
25
2021
949
2.930
Why?
Humans
133
2024
17611
2.880
Why?
Aged
75
2024
6095
2.850
Why?
Polycystic Ovary Syndrome
6
2022
19
2.730
Why?
Middle Aged
89
2024
7911
2.510
Why?
Hip Fractures
10
2023
67
2.500
Why?
Asian Americans
12
2022
176
2.180
Why?
Fractures, Bone
7
2023
91
2.160
Why?
California
41
2024
2284
2.160
Why?
Risk Factors
47
2024
3325
2.040
Why?
Retrospective Studies
29
2024
2447
1.970
Why?
Aged, 80 and over
29
2024
1900
1.940
Why?
Vitamin D
5
2024
76
1.780
Why?
Risk Assessment
26
2024
1097
1.770
Why?
Prevalence
18
2024
884
1.590
Why?
Kidney Failure, Chronic
7
2017
147
1.540
Why?
Diabetes Mellitus, Type 2
9
2024
748
1.500
Why?
Medication Adherence
3
2019
244
1.470
Why?
Antineoplastic Agents, Hormonal
3
2021
63
1.470
Why?
Male
50
2024
10008
1.440
Why?
Cohort Studies
35
2024
2570
1.430
Why?
Delivery of Health Care, Integrated
7
2024
531
1.330
Why?
Vitamin D Deficiency
4
2024
21
1.300
Why?
Obesity, Morbid
3
2024
120
1.270
Why?
Diabetes Mellitus
9
2024
487
1.260
Why?
Body Mass Index
17
2022
958
1.230
Why?
Renal Dialysis
4
2017
54
1.180
Why?
Ethnic Groups
7
2017
485
1.170
Why?
Pediatric Obesity
4
2020
81
1.140
Why?
Jaw Diseases
4
2011
9
1.130
Why?
Osteonecrosis
4
2011
10
1.130
Why?
Adult
49
2024
7598
1.130
Why?
European Continental Ancestry Group
9
2020
529
1.090
Why?
Incidence
17
2024
1255
1.050
Why?
Neoplasm Recurrence, Local
9
2019
244
1.040
Why?
Diabetes, Gestational
7
2017
340
0.990
Why?
Cardiovascular Diseases
7
2021
598
0.980
Why?
Cross-Sectional Studies
17
2024
1322
0.980
Why?
Electronic Health Records
6
2024
681
0.960
Why?
Patient Portals
1
2024
24
0.940
Why?
Pregnancy Complications
3
2017
196
0.930
Why?
Alendronate
5
2012
15
0.890
Why?
Overweight
7
2024
269
0.890
Why?
Follow-Up Studies
15
2020
1210
0.880
Why?
Age Factors
14
2018
917
0.880
Why?
Obesity
11
2024
837
0.880
Why?
Premature Birth
3
2015
137
0.870
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2019
171
0.860
Why?
Aromatase Inhibitors
3
2017
32
0.850
Why?
Sleep Apnea, Obstructive
1
2022
7
0.840
Why?
Hypothyroidism
2
2017
5
0.820
Why?
Sleep Wake Disorders
1
2022
37
0.820
Why?
Sleep Initiation and Maintenance Disorders
1
2022
39
0.800
Why?
Acquired Immunodeficiency Syndrome
1
2022
63
0.800
Why?
United States
21
2024
3956
0.780
Why?
Chronic Disease
6
2019
428
0.770
Why?
Adolescent
19
2024
3651
0.760
Why?
Renal Insufficiency, Chronic
8
2015
179
0.750
Why?
Survivors
8
2012
149
0.740
Why?
Time Factors
14
2020
1086
0.730
Why?
Hyperprolactinemia
2
2020
3
0.730
Why?
Surveys and Questionnaires
11
2024
1309
0.730
Why?
Continental Population Groups
4
2016
302
0.730
Why?
Hypertension
7
2017
500
0.730
Why?
Kidney Diseases
5
2011
53
0.730
Why?
Oceanic Ancestry Group
2
2019
33
0.720
Why?
Metatarsal Bones
1
2020
1
0.710
Why?
Ankle Fractures
1
2020
1
0.710
Why?
Prospective Studies
24
2019
1267
0.700
Why?
Administration, Oral
8
2020
85
0.680
Why?
Fractures, Spontaneous
1
2019
3
0.680
Why?
Intrauterine Devices, Medicated
1
2019
4
0.680
Why?
Contraceptive Agents, Female
1
2019
12
0.680
Why?
Medroxyprogesterone Acetate
1
2019
15
0.680
Why?
Contraceptives, Oral
1
2019
26
0.670
Why?
Osteoporosis, Postmenopausal
3
2012
42
0.670
Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
107
0.650
Why?
Pharmaceutical Services
1
2019
34
0.640
Why?
Hispanic Americans
5
2017
404
0.640
Why?
Insulin Resistance
5
2014
133
0.630
Why?
African Americans
6
2017
472
0.620
Why?
Lymphedema
3
2012
8
0.590
Why?
Thinness
2
2015
30
0.580
Why?
Nutritional Sciences
1
2017
11
0.580
Why?
Teaching
1
2017
14
0.580
Why?
Internal Medicine
1
2017
20
0.580
Why?
Thyroid Function Tests
1
2017
2
0.580
Why?
Glomerular Filtration Rate
10
2023
153
0.580
Why?
Education, Medical, Graduate
1
2017
18
0.570
Why?
Thyroid Gland
1
2017
4
0.570
Why?
Young Adult
16
2020
2427
0.570
Why?
Medication Therapy Management
1
2017
6
0.570
Why?
Internship and Residency
1
2017
45
0.560
Why?
Prehypertension
2
2013
22
0.530
Why?
Quality of Life
7
2024
507
0.520
Why?
Thyrotoxicosis
1
2015
2
0.500
Why?
Antithyroid Agents
1
2015
3
0.500
Why?
Pregnancy
12
2017
1494
0.500
Why?
Congenital Abnormalities
1
2015
26
0.500
Why?
Chemical and Drug Induced Liver Injury
1
2015
10
0.500
Why?
Weight Reduction Programs
1
2016
52
0.490
Why?
Child
12
2020
2474
0.490
Why?
Transition to Adult Care
1
2015
11
0.490
Why?
Treatment Outcome
6
2019
1259
0.480
Why?
Dizziness
3
2019
3
0.470
Why?
Osteosclerosis
2
2012
2
0.470
Why?
Neoplasm Staging
9
2021
325
0.470
Why?
Postural Balance
4
2019
10
0.470
Why?
Algorithms
2
2017
233
0.460
Why?
Databases, Factual
5
2019
309
0.440
Why?
Health Behavior
1
2016
359
0.440
Why?
Delivery of Health Care
1
2017
415
0.430
Why?
Pediatrics
1
2015
158
0.430
Why?
Parenting
1
2013
29
0.430
Why?
Cervix Uteri
1
2012
5
0.410
Why?
Uterine Cervical Diseases
1
2012
2
0.410
Why?
Bisphosphonate-Associated Osteonecrosis of the Jaw
1
2012
1
0.410
Why?
Multiple Myeloma
1
2012
9
0.410
Why?
Postmenopause
4
2017
241
0.400
Why?
Menopause
4
2015
68
0.400
Why?
Tamoxifen
2
2017
56
0.400
Why?
Perimenopause
1
2011
11
0.390
Why?
China
4
2020
130
0.390
Why?
Mouth Diseases
1
2011
3
0.380
Why?
Oral Health
1
2011
21
0.370
Why?
HIV Infections
3
2023
694
0.360
Why?
Prognosis
12
2020
606
0.360
Why?
Health Promotion
1
2013
280
0.360
Why?
Lactation
4
2015
52
0.360
Why?
Dental Implantation, Endosseous
1
2010
1
0.350
Why?
Dental Implants
1
2010
2
0.350
Why?
Dental Restoration Failure
1
2010
6
0.350
Why?
Blood Pressure
4
2017
298
0.350
Why?
Cholesterol, LDL
3
2016
119
0.340
Why?
Retinal Diseases
3
2015
16
0.330
Why?
Child, Preschool
9
2017
1409
0.320
Why?
Primary Health Care
1
2015
766
0.320
Why?
Estrogen Receptor alpha
2
2015
25
0.320
Why?
Cholesterol, HDL
2
2014
79
0.320
Why?
Drug Prescriptions
3
2019
151
0.310
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
9
0.310
Why?
Alcohol Drinking
2
2012
368
0.310
Why?
Prediabetic State
2
2022
56
0.300
Why?
Diet
4
2019
365
0.300
Why?
Gait
3
2018
6
0.300
Why?
Femur
2
2020
10
0.290
Why?
Breast Feeding
3
2015
133
0.280
Why?
Age Distribution
4
2016
246
0.280
Why?
Gonadal Steroid Hormones
1
2006
26
0.270
Why?
Receptors, Progesterone
2
2015
50
0.270
Why?
Sex Distribution
3
2024
190
0.260
Why?
Absorptiometry, Photon
3
2016
50
0.260
Why?
Neoplasms, Second Primary
1
2016
29
0.260
Why?
Lactic Acid
1
2005
9
0.260
Why?
Fasting
1
2005
48
0.260
Why?
Reverse Transcriptase Inhibitors
1
2005
24
0.260
Why?
Maternal Age
2
2017
77
0.250
Why?
Bone Resorption
2
2016
4
0.250
Why?
Polymorphism, Single Nucleotide
1
2006
373
0.240
Why?
Asian Continental Ancestry Group
4
2013
90
0.240
Why?
Fatigue
2
2022
34
0.240
Why?
Hospitalization
3
2022
797
0.230
Why?
Patient Compliance
1
2006
298
0.230
Why?
Disease Progression
6
2019
264
0.230
Why?
Proportional Hazards Models
8
2017
709
0.220
Why?
Severity of Illness Index
7
2014
454
0.220
Why?
Retina
2
2015
25
0.210
Why?
Poverty
1
2024
166
0.210
Why?
Diabetic Nephropathies
1
2023
26
0.210
Why?
Independent Living
1
2022
21
0.210
Why?
Risk
4
2017
516
0.210
Why?
Hypertensive Retinopathy
2
2012
3
0.210
Why?
Fibroblast Growth Factors
2
2013
11
0.210
Why?
Diabetic Retinopathy
2
2012
18
0.210
Why?
Anti-HIV Agents
1
2023
155
0.200
Why?
Logistic Models
6
2015
926
0.200
Why?
Radiography
2
2012
39
0.200
Why?
Tooth Extraction
2
2012
5
0.190
Why?
Injections, Intravenous
2
2012
10
0.190
Why?
Heart Failure
2
2022
396
0.190
Why?
Health Surveys
2
2016
260
0.190
Why?
Coronary Artery Disease
2
2016
134
0.190
Why?
Leptin
2
2014
29
0.180
Why?
Japan
1
2020
14
0.180
Why?
Pregnancy Outcome
2
2012
154
0.180
Why?
Philippines
1
2020
22
0.180
Why?
Gene Expression Regulation, Neoplastic
2
2015
51
0.180
Why?
Diet Surveys
1
2010
57
0.180
Why?
Body Height
1
2020
62
0.180
Why?
Survival Analysis
5
2012
215
0.180
Why?
Acne Vulgaris
1
2020
8
0.180
Why?
Dopamine Agonists
1
2020
3
0.180
Why?
Interviews as Topic
3
2012
305
0.180
Why?
Accidental Falls
2
2017
38
0.180
Why?
Dyslipidemias
2
2014
62
0.180
Why?
Risk Reduction Behavior
2
2016
108
0.170
Why?
Heart Valve Diseases
1
2020
20
0.170
Why?
Levonorgestrel
1
2019
5
0.170
Why?
Infant, Newborn
4
2015
844
0.170
Why?
Health Knowledge, Attitudes, Practice
1
2012
375
0.170
Why?
Progestins
1
2019
25
0.170
Why?
Drug Administration Schedule
1
2019
98
0.170
Why?
Collagen Type I
2
2016
6
0.170
Why?
Peptides
2
2016
12
0.170
Why?
Comorbidity
3
2017
594
0.160
Why?
Case-Control Studies
4
2010
1115
0.160
Why?
Sex Factors
4
2017
643
0.160
Why?
Population Surveillance
1
2010
263
0.160
Why?
Motor Activity
3
2013
212
0.160
Why?
Lipids
2
2019
77
0.150
Why?
Mass Screening
2
2014
661
0.150
Why?
Mothers
1
2009
105
0.150
Why?
Feeding Behavior
1
2009
166
0.150
Why?
Urinary Bladder Neoplasms
1
2019
56
0.150
Why?
Mastectomy
1
2017
36
0.150
Why?
Family Health
1
2017
44
0.150
Why?
Chemotherapy, Adjuvant
1
2017
70
0.150
Why?
Teaching Materials
1
2017
4
0.150
Why?
Morbidity
1
2017
59
0.140
Why?
Ibuprofen
1
2007
9
0.140
Why?
Vestibular Diseases
1
2017
1
0.140
Why?
Curriculum
1
2017
35
0.140
Why?
Mobility Limitation
1
2017
16
0.140
Why?
Body Weight
3
2016
219
0.140
Why?
Neoplasm Invasiveness
3
2012
78
0.140
Why?
Clinical Decision-Making
1
2017
34
0.140
Why?
Maternal Welfare
1
2006
14
0.140
Why?
Perinatal Care
1
2006
12
0.140
Why?
Aspirin
1
2007
63
0.140
Why?
Exercise
1
2011
489
0.140
Why?
Breast Cancer Lymphedema
1
2016
4
0.140
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2007
65
0.140
Why?
Reference Values
1
2016
91
0.140
Why?
Blood Glucose
3
2015
341
0.140
Why?
Ergocalciferols
2
2014
3
0.130
Why?
Odds Ratio
5
2015
671
0.130
Why?
Patient-Centered Care
1
2018
197
0.130
Why?
Managed Care Programs
1
2017
325
0.130
Why?
Counseling
1
2017
189
0.130
Why?
Methimazole
1
2015
2
0.130
Why?
Propylthiouracil
1
2015
2
0.130
Why?
Glucose Tolerance Test
2
2012
107
0.120
Why?
Hypoglycemic Agents
1
2017
268
0.120
Why?
Metabolic Syndrome
2
2006
80
0.120
Why?
Postpartum Period
2
2014
94
0.120
Why?
Infant
5
2015
1171
0.120
Why?
Carcinoma, Ductal, Breast
1
2015
53
0.120
Why?
Intensive Care Units, Neonatal
1
2015
41
0.120
Why?
Social Welfare
1
2014
13
0.120
Why?
Dietary Supplements
2
2014
87
0.120
Why?
Prenatal Exposure Delayed Effects
1
2006
160
0.120
Why?
Insulin
2
2012
205
0.120
Why?
Antineoplastic Agents
1
2014
59
0.120
Why?
Adiponectin
1
2014
21
0.120
Why?
Women's Health
2
2012
200
0.120
Why?
Biomarkers
2
2014
301
0.120
Why?
Registries
3
2016
471
0.110
Why?
Multivariate Analysis
4
2013
568
0.110
Why?
Ventricular Remodeling
1
2013
6
0.110
Why?
Child Nutritional Physiological Phenomena
1
2013
7
0.110
Why?
Hip
1
2013
9
0.110
Why?
Bone and Bones
1
2013
9
0.110
Why?
Physical Examination
1
2013
20
0.110
Why?
Patient Readmission
1
2015
163
0.110
Why?
Femur Neck
1
2012
5
0.110
Why?
Health Education
1
2013
111
0.100
Why?
Fertilization in Vitro
1
2012
1
0.100
Why?
Gonadotropins
1
2012
1
0.100
Why?
Fertility
1
2012
8
0.100
Why?
Infertility
1
2012
4
0.100
Why?
Osteolysis
1
2012
1
0.100
Why?
Wound Healing
1
2012
5
0.100
Why?
Debridement
1
2012
3
0.100
Why?
Bone Diseases, Metabolic
1
2012
4
0.100
Why?
Antirheumatic Agents
1
2012
11
0.100
Why?
Glucocorticoids
1
2012
20
0.100
Why?
Reproducibility of Results
3
2017
381
0.100
Why?
Gestational Age
1
2012
111
0.100
Why?
Tomography, X-Ray Computed
2
2010
205
0.100
Why?
Linear Models
3
2014
231
0.100
Why?
Hormones
1
2011
14
0.100
Why?
Physician-Patient Relations
1
2013
187
0.100
Why?
Communication
1
2013
194
0.100
Why?
Glucose Intolerance
1
2011
45
0.100
Why?
Femoral Neck Fractures
1
2011
1
0.100
Why?
Clinical Coding
1
2011
11
0.100
Why?
Dental Care
1
2011
19
0.090
Why?
Diagnosis, Differential
1
2011
60
0.090
Why?
Antipsychotic Agents
1
2011
49
0.090
Why?
Coronary Disease
2
2016
181
0.090
Why?
Tunica Intima
1
2011
9
0.090
Why?
Carotid Arteries
1
2011
9
0.090
Why?
Carotid Artery Diseases
1
2011
12
0.090
Why?
Tooth Mobility
1
2010
1
0.090
Why?
Oral Fistula
1
2010
1
0.090
Why?
Tooth Socket
1
2010
1
0.090
Why?
Radiography, Panoramic
1
2010
2
0.090
Why?
Facial Pain
1
2010
5
0.090
Why?
Life Style
3
2019
332
0.090
Why?
Vitamins
1
2011
64
0.090
Why?
Combined Modality Therapy
2
2018
145
0.090
Why?
Practice Patterns, Physicians'
1
2013
330
0.090
Why?
Anti-Bacterial Agents
1
2012
140
0.090
Why?
Models, Statistical
1
2011
177
0.090
Why?
Osseointegration
1
2010
3
0.090
Why?
Forecasting
1
2010
75
0.090
Why?
Etidronic Acid
1
2009
3
0.090
Why?
Technetium Compounds
1
2009
1
0.080
Why?
Radionuclide Imaging
1
2009
4
0.080
Why?
Imidazoles
1
2009
4
0.080
Why?
Radiopharmaceuticals
1
2009
12
0.080
Why?
Exercise Therapy
2
2018
71
0.080
Why?
Early Diagnosis
1
2009
38
0.080
Why?
Receptor, ErbB-2
2
2015
46
0.080
Why?
Parity
1
2009
74
0.080
Why?
Self Report
2
2016
251
0.080
Why?
Survival Rate
3
2010
260
0.070
Why?
Demography
2
2013
101
0.070
Why?
Random Allocation
2
2017
37
0.070
Why?
Abdomen
1
2006
20
0.070
Why?
17-Hydroxysteroid Dehydrogenases
1
2006
3
0.070
Why?
Aromatase
1
2006
7
0.070
Why?
Estrogen Receptor beta
1
2006
10
0.070
Why?
Calcinosis
1
2006
40
0.070
Why?
Chi-Square Distribution
2
2010
154
0.070
Why?
Adiposity
1
2006
66
0.070
Why?
African Continental Ancestry Group
1
2006
162
0.070
Why?
Socioeconomic Factors
2
2015
630
0.060
Why?
Cell Proliferation
1
2015
19
0.060
Why?
Neoplasms
1
2009
438
0.060
Why?
Tenofovir
1
2023
18
0.060
Why?
Albuminuria
1
2023
38
0.050
Why?
Meals
1
2022
7
0.050
Why?
Retinal Vessels
2
2012
4
0.050
Why?
Confidence Intervals
1
2012
237
0.050
Why?
Longitudinal Studies
3
2010
710
0.050
Why?
Myocardial Infarction
2
2016
238
0.050
Why?
Kidney
2
2014
52
0.050
Why?
Sensitivity and Specificity
2
2012
304
0.050
Why?
Stroke
2
2016
311
0.050
Why?
Cluster Analysis
1
2021
89
0.050
Why?
Time
1
2020
20
0.050
Why?
Lymphatic Metastasis
1
2010
29
0.050
Why?
Diet Records
1
2010
36
0.050
Why?
Predictive Value of Tests
2
2015
351
0.040
Why?
Patient Discharge
1
2022
154
0.040
Why?
Energy Intake
1
2010
101
0.040
Why?
Educational Status
1
2010
200
0.040
Why?
Benign Paroxysmal Positional Vertigo
1
2019
1
0.040
Why?
Proton Pump Inhibitors
1
2020
24
0.040
Why?
Adaptation, Psychological
1
2010
77
0.040
Why?
Nutrition Assessment
1
2009
26
0.040
Why?
Nutrition Surveys
1
2009
61
0.040
Why?
Emergency Service, Hospital
1
2022
358
0.040
Why?
Vestibule, Labyrinth
1
2018
1
0.040
Why?
New South Wales
1
2018
2
0.040
Why?
Recovery of Function
1
2018
27
0.040
Why?
Single-Blind Method
1
2018
44
0.040
Why?
Disability Evaluation
1
2018
46
0.040
Why?
Home Care Services
1
2018
22
0.040
Why?
Social Support
1
2010
203
0.040
Why?
Cancer Survivors
1
2019
83
0.040
Why?
Chemoprevention
1
2007
12
0.040
Why?
Drug Substitution
1
2017
10
0.040
Why?
Diastole
1
2017
5
0.040
Why?
New Zealand
1
2017
5
0.040
Why?
Australia
1
2017
22
0.040
Why?
Systole
1
2017
22
0.040
Why?
Sample Size
1
2017
29
0.040
Why?
Minnesota
1
2017
53
0.040
Why?
Secondary Prevention
1
2007
47
0.040
Why?
Nonprescription Drugs
1
2006
6
0.030
Why?
Menstruation
1
2016
7
0.030
Why?
Colorado
1
2017
163
0.030
Why?
Age of Onset
1
2016
79
0.030
Why?
Lipid Metabolism
1
2015
13
0.030
Why?
Research Design
2
2011
374
0.030
Why?
Anxiety
1
2017
150
0.030
Why?
Primary Prevention
1
2016
73
0.030
Why?
Referral and Consultation
1
2017
167
0.030
Why?
Decision Making
1
2017
183
0.030
Why?
Health Status Disparities
1
2017
146
0.030
Why?
Cross-Over Studies
1
2014
45
0.030
Why?
Venules
1
2014
1
0.030
Why?
Arterioles
1
2014
2
0.030
Why?
Retinal Artery
1
2014
2
0.030
Why?
Retinal Vein
1
2014
2
0.030
Why?
Nonlinear Dynamics
1
2014
7
0.030
Why?
Fatty Acids, Nonesterified
1
2014
12
0.030
Why?
Lipoproteins
1
2014
14
0.030
Why?
Parathyroid Hormone
1
2014
9
0.030
Why?
Cholecalciferol
1
2014
15
0.030
Why?
Triglycerides
1
2014
86
0.030
Why?
Kaplan-Meier Estimate
1
2014
129
0.030
Why?
Muscle Weakness
1
2013
3
0.030
Why?
Genetic Predisposition to Disease
1
2015
368
0.030
Why?
Osteocalcin
1
2012
4
0.030
Why?
Photography
1
2012
9
0.030
Why?
Remission Induction
1
2012
25
0.030
Why?
ROC Curve
1
2012
77
0.030
Why?
Proteinuria
1
2012
26
0.030
Why?
Fluorescein Angiography
1
2012
7
0.030
Why?
Stroke Volume
1
2013
100
0.030
Why?
Myocardial Revascularization
1
2012
12
0.030
Why?
Practice Guidelines as Topic
1
2014
318
0.030
Why?
Depression
1
2017
502
0.030
Why?
Outcome and Process Assessment (Health Care)
1
2012
102
0.030
Why?
Infant Food
1
2011
8
0.030
Why?
Bottle Feeding
1
2011
8
0.020
Why?
Physicians
1
2013
137
0.020
Why?
World Health Organization
1
2011
14
0.020
Why?
Area Under Curve
1
2011
33
0.020
Why?
Regression Analysis
1
2011
297
0.020
Why?
Weight Loss
1
2013
303
0.020
Why?
Fundus Oculi
1
2010
3
0.020
Why?
Diagnostic Techniques, Ophthalmological
1
2010
6
0.020
Why?
Outcome Assessment (Health Care)
1
2011
228
0.020
Why?
Health Maintenance Organizations
1
2011
417
0.020
Why?
Receptors, Estrogen
1
2009
51
0.020
Why?
Geography
1
2008
39
0.020
Why?
Abdominal Fat
1
2006
14
0.020
Why?
Poisson Distribution
1
2006
88
0.020
Why?
Hyperlipidemias
1
2006
53
0.020
Why?
Cause of Death
1
2006
181
0.020
Why?
Kidney Function Tests
1
2003
22
0.010
Why?
Patient Selection
1
2003
190
0.010
Why?
Concepts (433)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente